📰 Clinical Study Program News
Clinical Study Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Clinical Study Program. Real-time updates on events, politics, business and more.
June 1, 2023
Cosentyx® is the first new biologic treatment for hidradenitis suppurativa in nearly a decade, offering clinically meaningful results across the most debilitating... | June 1, 2023
April 27, 2023
Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa •    Positive opinion paves way for first new treatment option in hidradenitis suppurativa (HS) in nearly a decade •    Committee for Medicinal Products for Human Use (CHMP) opinion based...
April 26, 2023
Positive opinion paves way for first new treatment option in hidradenitis suppurativa (HS) in nearly a decade Committee for Medicinal Products for Human Use (CHMP) opinion based on robust Phase
April 26, 2023
Investegate announcements from NOVARTIS AG CHF0.50(REGD), Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa
April 26, 2023
Positive opinion paves way for first new treatment option in hidradenitis suppurativa in nearly a decade Committee for Medicinal Products for Human Use opinion based on robust Phase III data... | April 26, 2023
April 26, 2023
Positive opinion paves way for first new treatment option in hidradenitis suppurativa (HS) in nearly a decade Committee for Medicinal Products for...